Treatment with rabbit antithymocyte serum permits a cyclophosphamide-free approach to prevention of hDAF transgenic porcine kidney xenograft rejection in baboons.
Ghanekar
A
A
Department of Surgery, University of Toronto, and Multi-Organ Transplant Program, Toronto General Hospital Toronto,Ontario, Canada.
Lajoie
G
G
Luo
Y
Y
Yang
H
H
Choi
J
J
Garcia
B
B
Greig
P D
PD
Cattral
M S
MS
Cole
E H
EH
Phillips
M J
MJ
Cardella
C J
CJ
Levy
G A
GA
Zhong
R
R
Grant
D R
DR
D000818:Animals; D030801:Animals, Genetically Modified; D015703:Antigens, CD / Q000235:genetics; D000961:Antilymphocyte Serum / Q000627:therapeutic use*; D018958:CD55 Antigens / Q000235:genetics*; D003520:Cyclophosphamide / Q000627:therapeutic use; D006084:Graft Rejection / Q000517:prevention & control*; D006801:Humans; D007166:Immunosuppressive Agents / Q000627:therapeutic use*; D016030:Kidney Transplantation / Q000276:immunology*; D010215:Papio; D011817:Rabbits; D013552:Swine; D014183:Transplantation, Heterologous / Q000276:immunology*
D015703:Antigens, CD; D000961:Antilymphocyte Serum; D018958:CD55 Antigens; D007166:Immunosuppressive Agents; D003520:Cyclophosphamide